Atomoxetine 60mg

Atomoxetine 60mg is a non-stimulant medicine used for attention-deficit/hyperactivity disorder (ADHD). It is a selective norepinephrine reuptake inhibitor and can help improve attention, impulse control, and hyperactivity symptoms as part of a broader ADHD management plan that may include behavioural, educational, sleep, and routine-based support.
Take Atomoxetine 60mg exactly as prescribed, usually once daily in the morning or split between morning and late afternoon/evening if directed. It can be taken with or without food. Do not open capsules unless a clinician gives specific instructions; atomoxetine powder can irritate the eyes. Do not stop or change dose without review.
Atomoxetine selectively increases norepinephrine signalling by blocking norepinephrine reuptake. This supports attention and impulse-control pathways without being a traditional stimulant.
Possible side effects include nausea, reduced appetite, stomach pain, vomiting, dry mouth, constipation, dizziness, sleepiness, insomnia, tiredness, sweating, mood changes, increased heart rate, increased blood pressure, and sexual side effects in adults. Serious concerns include suicidal thoughts, liver injury, severe allergy, fainting, chest pain, urinary retention, or severe mood/behaviour change.
Do not use with MAO inhibitors or within the required washout period. Use caution in heart disease, high blood pressure, fast pulse, glaucoma, liver disease, bipolar disorder, suicidal ideation, pregnancy, breastfeeding, and strong CYP2D6 inhibitor use. Monitor growth, appetite, mood, BP, and pulse in children and adolescents.
Supports attention, impulse control, and hyperactivity management without being a classic stimulant, and may suit patients for ADHD treatment without stimulant therapy.
Atomoxetine 60mg is used for ADHD to help improve attention, impulsivity, and hyperactivity symptoms when prescribed.
No. Atomoxetine is a non-stimulant selective norepinephrine reuptake inhibitor.
Some changes may appear earlier, but meaningful benefit often takes several weeks and dose adjustment may be needed.
Seek urgent advice for suicidal thoughts, worsening mood, aggression, agitation, unusual behaviour, or severe anxiety.
Yes. Appetite and weight changes can occur, so growth and weight should be monitored in children and adolescents.
MAO inhibitors are unsafe, and fluoxetine, paroxetine, quinidine, and some other medicines can increase atomoxetine exposure.
Atomoxetine, Non stimulant ADHD medicine, Selective norepinephrine reuptake inhibitor, Attention deficit hyperactivity disorder treatment, ADHD focus medicine, Atomoxetine mood monitoring, AR: Atomoxetine أقراص, FR: Atomoxetine comprimé, PT: Atomoxetine comprimido, ES: Atomoxetine tableta, RU: Atomoxetine таблетки, ID: Atomoxetine, VI: Atomoxetine viên nén, MS: Atomoxetine, TL: Atomoxetine tableta, ZH-SG: Atomoxetine 片剂
International B2B Enquiry
Send a structured B2B enquiry for Atomoxetine 60mg under Neuro / Mental Health. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Atomoxetine 60mg